|
|
|
|
| LEADER |
01970nam a2200349 u 4500 |
| 001 |
EB000943520 |
| 003 |
EBX01000000000000000737110 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 100 |
1 |
|
|a Dailey, Janet H.
|
| 245 |
0 |
0 |
|a Drug class review on newer antiplatelet agents
|h Elektronische Ressource
|b final report update 1
|c Janet H. Dailey ... [et al.]
|
| 260 |
|
|
|a Portland, Or.
|b Oregon Health & Science University, Evidence-Based Practice Center
|c c2007, 2007
|
| 300 |
|
|
|a 1 PDF file (91 p.)
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Comparative Effectiveness Research
|
| 653 |
|
|
|a Drug Evaluation
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Platelet Aggregation Inhibitors / therapeutic use
|
| 653 |
|
|
|a Platelet Aggregation Inhibitors / adverse effects
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Vascular Diseases / drug therapy
|
| 653 |
|
|
|a Platelet Aggregation Inhibitors / pharmacokinetics
|
| 710 |
2 |
|
|a Oregon Health & Science University
|b Evidence-based Practice Center
|
| 710 |
2 |
|
|a Southern California Evidence-Based Practice Center/RAND.
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 500 |
|
|
|a "April, 2007."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK10384
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 856 |
4 |
0 |
|u http://derp.ohsu.edu/final/AP_Final_Report_Update%2014.pdf
|3 Volltext
|n Free Electronic Resource
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a "The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports."
|